Cagrilintide

Product Overview

• Core Molecule: Cagrilintide (Long-acting Amylin Analog)

• Research Grade: Amino Grade / Ultra-High Purity HPLC Tested

• Formulation: Lyophilized (Freeze-Dried) Solid

• Sequence: 39 Amino Acid acylated peptide

Key Research Highlights

• Dual Receptor Agonist: Designed to target both Amylin and Calcitonin receptors, providing a distinct pathway for appetite regulation compared to standard incretin mimetics.

• Synergistic Potential: Frequently studied in combination with Semaglutide (forming the "CagriSema" complex) to investigate enhanced weight-loss efficacy and metabolic markers.

• Glucagon Modulation: Research focuses on its ability to suppress postprandial glucagon secretion, leading to improved glucose stability in laboratory models.

• Gastric Kinetic Studies: Investigated for its role in slowing gastric emptying, which contributes to prolonged feelings of satiety and reduced caloric intake.

• Extended Half-Life: Features specific lipid-acid conjugation (acylation) that allows for prolonged activity and stability during long-term research protocols.

Technical Specifications & Quality

• Purity: ≥99% purity as verified by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry.

• Molecular Weight: Approximately $4409.0\text{ g/mol}$.

• Manufacturing: Synthesized via advanced solid-phase peptide synthesis (SPPS) for maximum sequence precision.

• Reconstitution: Optimized for high solubility in Bacteriostatic Water ($0.9\%\text{ Benzyl Alcohol}$).

• Format: Multi-dose research vial with a vacuum-sealed nitrogen environment to prevent oxidation.